Operating in Australia since 2012, and with a presence in New Zealand from 2015, Menarini ANZ is a biopharmaceutical company focused on delivering differentiated pharmaceutical and consumer health brands. Leveraging the extensive global infrastructure and go-to-market expertise of the Menarini Group, and our unique insights of Asia-Pacific markets, we support products from research and development, through to manufacturing, regulatory approvals, sales and marketing.

With more than 75 employees locally, we provide treatments in the areas of allergy and respiratory, cardiovascular disease, dermatology, gastroenterology, men’s health, pain, and select specialty care. Through our expertise in establishing in-license partnerships, we deliver a wide range of prescription, non-prescription, biological and highly specialised treatments, while also expanding our product pipeline in areas such as oncology, anti-infectives and haematology.

We are passionate about advancing healthcare to meet the needs of patients and consumers, and are driven by a greater sense of purpose to improve their quality of life.